[Long-term outcomes of intradetrusor botulinum toxin A in multiple sclerosis patients].
CONCLUSION: Botulinum toxin remains the second-line reference treatment for detrusor overactivity of neurological origin. There is, at least in the short term, a good answer in a large number of cases. This response can be maintained for many years, especially if patients use intermittent catheterization, with excellent tolerance.
LEVEL OF EVIDENCE: 4.
PMID: 30880066 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
More News: Bladder Catheterization | Brain | Hyperactivity | Multiple Sclerosis | Neurology | Study | Urinary Tract Infections | Urology & Nephrology